Surgery Partners, Inc. (NASDAQ:SGRY) Receives Average Recommendation of “Moderate Buy” from Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY) has received an average rating of “Moderate Buy” from the ten ratings firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $27.1111.

A number of brokerages have recently commented on SGRY. Mizuho lowered their price objective on Surgery Partners from $22.00 to $19.00 and set an “outperform” rating for the company in a research report on Thursday, December 18th. Benchmark decreased their price target on shares of Surgery Partners from $35.00 to $30.00 and set a “buy” rating for the company in a research note on Tuesday, November 11th. JPMorgan Chase & Co. dropped their price objective on shares of Surgery Partners from $27.00 to $20.00 and set a “neutral” rating on the stock in a research report on Monday, November 24th. UBS Group reduced their price objective on shares of Surgery Partners from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Thursday, November 13th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Surgery Partners in a research report on Monday, December 29th.

Surgery Partners Trading Down 0.2%

Shares of SGRY opened at $15.46 on Thursday. Surgery Partners has a 12-month low of $13.14 and a 12-month high of $26.16. The firm has a market capitalization of $2.00 billion, a P/E ratio of -11.37 and a beta of 1.97. The firm has a 50-day moving average price of $15.43 and a 200 day moving average price of $18.83. The company has a current ratio of 1.88, a quick ratio of 1.72 and a debt-to-equity ratio of 1.10.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Pentwater Capital Management LP raised its stake in Surgery Partners by 66.9% during the 3rd quarter. Pentwater Capital Management LP now owns 11,681,000 shares of the company’s stock valued at $252,777,000 after acquiring an additional 4,681,000 shares during the last quarter. UBS Group AG increased its holdings in shares of Surgery Partners by 111.4% in the fourth quarter. UBS Group AG now owns 7,803,974 shares of the company’s stock valued at $120,571,000 after purchasing an additional 4,113,052 shares during the period. Vanguard Group Inc. raised its stake in shares of Surgery Partners by 5.9% during the third quarter. Vanguard Group Inc. now owns 7,614,514 shares of the company’s stock worth $164,778,000 after purchasing an additional 424,518 shares during the last quarter. King Street Capital Management L.P. lifted its holdings in shares of Surgery Partners by 24.5% during the second quarter. King Street Capital Management L.P. now owns 6,225,000 shares of the company’s stock worth $138,382,000 after purchasing an additional 1,225,000 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in Surgery Partners by 1.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,906,580 shares of the company’s stock valued at $75,808,000 after buying an additional 46,365 shares during the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.